METHRO II

METHRO II

Abbreviation for:
Melagatran Thromboprophylaxis in Orthopaedic surgery II
References in periodicals archive ?
Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial.
The primary purpose of the METHRO II Study, which involved a total of 1,916 patients in 13 European countries, was to compare the efficacy of various dosage regimens of H376/95 given orally preceded by the subcutaneous administration of melagatran.
In the METHRO II Study, total bleeding did not differ statistically between treatment groups or dalteparin.
Ortopedik cerrahi uygulanan olgularda venoz tromboembolinin onlenmesine yonelik ximelagatran ile dusuk molekuler agirlikli heparinin karsilastirildigi METHRO I, METHRO II ve THRIVE calismalari, ximelagatranin major/minor kanama oranlarini artirmadan, venoz tromboemboli gorulme sikligini azaltmada dusuk molekuler agirlikli heparinler kadar etkin oldu gu gostermistir (2).